Inflammatory bowel disease and osteoporosis

被引:0
|
作者
Ljunghall, S [1 ]
Ljunggren, Ö [1 ]
机构
[1] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden
来源
ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 1999年 / 31卷 / 02期
关键词
bone mineral density; corticosteroids; inflammatory bowel disease; osteoporosis;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with inflammatory bowel disease are at increased risk to develop osteoporosis due to the underlying inflammatory process, as a result of the intestinal dysfunction and as a consequence of the treatment given to counteract the disease. Furthermore, patients with inflammatory bowel disease presumably share with the general population other common risk factors for osteoporosis, e.g. heredity, smoking, inactivity and hormone deficiency. Most recent investigations demonstrate a reduced bone mineral density in inflammatory bowel disease patients, often more apparent in the femoral neck than in the lumbar spine, but there are no controlled fracture studies in these patients. There is , at the bone tissue level, evidence for a negative remodelling balance, i.e., increased resorption with or without suppressed formation and it is commonly found that corticosteroid use significantly contributes to bone loss. Although controlled studies are few, patients with inflammatory bowel disease should be informed about osteoporosis, have their bone mineral density measured and receive general advice including hormone replacement therapy, calcium and vitamin D. In more severe cases antiresorptive therapy might be instituted under close supervision.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [31] COMPARATIVE STUDY OF OSTEOPOROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Rogoveanu, O. C.
    Rogoveanu, I.
    Ionele, C.
    Cioroianu, G-O.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S375 - S376
  • [32] Assessing the Risk of Osteoporosis in Patients with Inflammatory Bowel Disease
    Sarmini, Muhammad Talal
    Asfari, Mohammad Maysara
    Al-Khadra, Yasser
    Dasarathy, Srinivasan
    McCullough, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S373 - S373
  • [33] MECHANISM OF OSTEOPOROSIS IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
    BJARNASON, I
    LI, F
    BUXTONTHOMAS, M
    FORGACS, I
    MONIZ, C
    MACPHERSON, A
    GASTROENTEROLOGY, 1994, 106 (04) : A652 - A652
  • [34] High frequency of osteoporosis in inflammatory bowel disease (IBD)
    Bregenzer, N
    Andus, T
    Lehner, G
    Gross, V
    Scholmerich, J
    GASTROENTEROLOGY, 1996, 110 (04) : A872 - A872
  • [35] Risk factors and management of osteoporosis in inflammatory bowel disease
    Targownik, Laura E.
    Bernstein, Charles N.
    Leslie, William D.
    CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (02) : 168 - 174
  • [36] OSTEOPOROSIS - A SERIOUS COMPLICATION OF INFLAMMATORY BOWEL-DISEASE
    CLEMENTS, D
    COMPSTON, J
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (09) : 757 - 760
  • [37] Basic and clinical aspects of osteoporosis in inflammatory bowel disease
    Lorena Rodríguez-Bores
    JosuéBarahona-Garrido
    Jesús K Yamamoto-Furusho
    World Journal of Gastroenterology, 2007, (46) : 6156 - 6165
  • [38] Screening for osteoporosis in inflammatory bowel disease: A British perspective
    Babu, PS
    Mak, S
    Heatley, RV
    GASTROENTEROLOGY, 2001, 120 (05) : A628 - A629
  • [39] Prevalence of osteoporosis in Malaysian patients with inflammatory bowel disease
    Hilmi, S. Ida
    Ananda, V.
    Sazilla, A. S.
    Goh, K. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A78 - A78
  • [40] Osteoporosis in adult Sri Lankan inflammatory bowel disease patients
    Arjuna Priyadarsin de Silva
    Aranjan Lionel Karunanayake
    Thalahitiya Gamaralalage Iruka Dissanayaka
    Anuradha Supun Dassanayake
    Hewa Kattadi Kankanamgae Tilak Duminda
    Arunasalam Pathmeswaran
    Ananda Rajitha Wickramasinghe
    Hithanadura Janaka de Silva
    World Journal of Gastroenterology, 2009, 15 (28) : 3528 - 3531